A

Arrowhead Pharmaceuticals

Develops RNAi-based gene-silencing therapies

Quality Assurance Specialist 3 - Early Phase Quality Operations

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeVerona, WI, USA$78k - $98k

About the Job

Requirements

  • A BS/BA in an applicable scientific field such as chemistry, biology, or biochemistry is required.
  • A minimum of 5 years of quality assurance or similar experience in biotech or pharmaceutical development, manufacturing, or a contract manufacturing organization is required, including experience supporting early phase clinical programs.
  • Working knowledge of Good Manufacturing Practice, Good Clinical Practice, and/or Good Distribution Practice regulations and International Council for Harmonisation and Food and Drug Administration guidance documents is required, including phase-appropriate application of Good Manufacturing Practice to investigational products.
  • Experience reviewing batch records, certificates of analysis, and testing records generated by external manufacturers and laboratories is required.
  • Strong verbal and written communication skills are required to communicate professionally with external parties.
  • Ability to follow company procedures, work instructions, and policies is required.
  • Attention to detail and organizational skills are required.
  • Ability to work independently with minimal supervision and manage priorities in a fast-paced environment is required.
  • Ability to travel occasionally, up to 10%, to support vendor oversight is required.
  • Candidates must have current, valid authorization to work in the country where the role is located.

Responsibilities

  • Interact with personnel companywide to obtain information needed to provide quality assurance support for early phase clinical programs.
  • Serve as a day-to-day Quality Assurance contact for contract manufacturers, contract testing laboratories, clinical packaging and labeling providers, and clinical supply depots supporting early phase programs.
  • Review and approve vendor-generated documentation for early phase clinical material, including master and executed batch records, testing records, certificates of analysis, labels, protocols, and reports, against approved specifications and applicable IND/CTA/IMPD.
  • Review clinical label text and labeling records from packaging and labeling vendors, including label reconciliation and verification of required regional content.
  • Perform lot disposition of investigational product under the applicable quality agreement and generate certificates of compliance as necessary.
  • Assemble and review documentation packages supporting Qualified Person release of product supplied to studies outside the United States, as assigned.
  • Collaborate with vendors on quality events and non-conformances under applicable quality agreements, including reviewing vendor deviations, out-of-specification and out-of-trend results, and investigations, and tracking events to timely closure.
  • Review vendor change notifications and support Arrowhead's assessment of their impact on investigational product.
  • Review vendor stability protocols, reports, and data supporting early phase material, as assigned.
  • Support evaluation of shipping and storage temperature excursions affecting investigational product held at vendors, clinical supply depots, and clinical sites.
  • Support vendor qualification activities, including quality questionnaires, audit scheduling and logistics, audit response tracking, and maintenance of quality agreement records, as necessary and assigned.
  • Support technical transfer to vendors through review of transfer-related documentation, as assigned.
  • Assist with tracking vendor quality metrics, including batch record review cycle time, quality event aging, and right-first-time performance, and notify Quality Assurance management of performance issues.
  • Assist with preparation, update, review, and routing of Arrowhead procedural documents, as necessary.
  • Scan and upload executed documents to the electronic document management system, categorize them appropriately, and route them for verification and approval.
  • Draft, review, and approve standard operating procedures and work instructions as needed.
  • Maintain knowledge of current compliance expectations and regulations for early phase drug development and investigational product supply, including 21 CFR Parts 210/211, Food and Drug Administration current Good Manufacturing Practice guidance for Phase 1 investigational drugs, ICH Q7, and EU GMP Annex 13.
  • Assist with Quality Assurance duties as needed.

Desired Qualifications

  • Prior experience using an electronic document management system in a regulated environment is preferred.
  • Competent knowledge of and ability to use Adobe Acrobat, Microsoft Office programs, and SmartSheet.
  • Experience supporting IND/CTA/IMPD-enabling programs and first-in-human study starts.
  • Experience supporting Qualified Person release or clinical trial supply to studies outside the United States.
  • Experience with oligonucleotide, peptide, or biologic modalities and/or sterile drug product.
  • Experience with quality agreements and vendor quality metrics programs.

About the Company

Arrowhead Pharmaceuticals

Develops RNAi-based gene-silencing therapies

Arrowhead Pharmaceuticals develops medicines using RNA interference (RNAi) to silence disease-causing genes. The company’s approach uses a library of RNA chemistries and delivery methods to trigger RNAi, enabling rapid and durable reduction of target gene expression in cells. This gene-silencing strategy aims to treat severe genetic diseases such as cystic fibrosis and hepatitis B by lowering disease-related proteins. Arrowhead’s products are advanced through discovery and development partnerships, licensing deals, and potential commercialization of approved therapies. The company differentiates itself through a broad RNAi platform, proprietary delivery tech, and collaborations with larger pharma firms to advance its pipeline. Its goal is to provide new treatment options for conditions with limited or no effective therapies by translating gene silencing into medicines that can halt or reverse disease progression.

Company size
501-1,000
Company stage
IPO
Headquarters
Pasadena, CA
Founded
2004

Recently Posted Jobs

Explore more opportunities at Arrowhead Pharmaceuticals

See more jobs